Christopher Boffi

Executive Director, Advisory
New York

Chris is an Executive Director in Perella Weinberg Partners’ advisory business. Chris has extensive experience in consumer segments with rapidly evolving regulatory environments, including reduced-harm nicotine, tobacco, cannabis, brewing and spirits.

Representative transactions in reduced-harm nicotine and tobacco include advising: Altria on several assignments, including its acquisition of a majority stake in on!, investment of a minority stake in JUUL, and acquisition of Nat Sherman; and the first lien creditors of Pyxus International during its Chapter 11 bankruptcy.

Representative transactions in cannabis include advising: Parallel on its merger with Ceres Acquisition Corp. (+ simultaneous $225 million PIPE capital raise) and acquisition of Windy City Cannabis; Altria on its investment in Cronos; and Cronos on its acquisition of Lord Jones.

Representative transactions in alcohol include advising: Altria on the sale of its 27% stake in SABMiller to ABI; City Brewing on its sale to Pabst Brewing Company; Castle Brands on its sale to Pernod Ricard; Heaven Hill on its acquisition of Deep Eddy Vodka; and Pabst Brewing Company on its sale to Eugene Kasper and TSG Consumer.

Chris has also advised other retail and consumer companies on a variety of M&A, shareholder activism and capital structure assignments. Representative transactions include advising: GameStop on its strategic review, sale of Spring Mobile to Prime Communications, cooperation agreement with activists Hestia Capital and Permit Capital, and exchange offer of outstanding senior notes; Kate Spade on its sale to Coach; Express on its takeover defense from Sycamore Partners; Coldwater Creek on its restructuring and sale of intellectual property to Sycamore Partners; and Henkel on its acquisition of Sun Products.

Chris received a Bachelor of Arts from University of Michigan in Behavioral Economics.